90Y数字PET/CT用于放射性栓塞后微球生物分布成像的临床可行性
本研究纳入5例接受90Y玻璃微球放射性栓塞的患者,比较数字光子计数PET/CT(dPET/CT)与标准护理韧致辐射SPECT/CT(bSPECT/CT)的成像质量与90Y生物分布。dPET/CT视觉图像质量和90Y-本底对比度更优,1%等值轮廓阈值可精确勾画治疗体积,而bSPECT/CT需20%阈值才能获得可比体积。dPET/CT用于评估90Y微球生物分布临床可行。
要点
- 5例患者接受90Y玻璃微球放射性栓塞后行dPET/CT与bSPECT/CT配对比较。
- dPET/CT视觉图像质量和90Y-本底对比度优于bSPECT/CT,采集时间可比。
- dPET/CT用1%阈值可精确勾画治疗体积,bSPECT/CT需20%阈值才可比。
核心结论
- 数字PET/CT用于评估放射性栓塞后90Y微球生物分布具有临床可行性,视觉图像质量和图像对比度优于常规bSPECT/CT,采集时间可比。
- 经进一步优化和临床验证,dPET技术可能实现更快、更准确的基于影像的90Y微球生物分布评估。
研究设计与样本
- 本研究为配对比较研究,纳入5例接受常规放射性栓塞、使用3.5 ± 1.7 GBq的90Y标记玻璃微球的患者。
- 所有患者在放射性栓塞后29 ± 11 h接受dPET/CT成像,并与标准护理bSPECT/CT进行配对比较。
- 比较指标包括图像质量、图像对比度和90Y生物分布,以及dPET/CT与bSPECT/CT不同等值轮廓阈值下的90Y活性体积评估。
主要发现
- dPET/CT在描绘90Y生物分布时,视觉图像质量和90Y-本底图像对比度一致优于bSPECT/CT。
- dPET/CT图像上使用1%等值轮廓阈值可精确勾画90Y活性和治疗体积。
- bSPECT/CT图像上需使用更严格的20%阈值才能获得与dPET/CT 1%阈值可比的治疗体积。
- bSPECT/CT图像上使用较宽松的10%等值轮廓阈值时,与dPET/CT 1%阈值相比,治疗体积被明显高估。
临床怎么用
- 作者认为,经进一步优化和临床验证,dPET技术可能实现更快、更准确的基于影像的90Y微球生物分布评估。
局限性
- 原文结论指出,dPET技术需进一步优化和临床验证。
- 本研究样本量为5例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to evaluate the clinical feasibility of next generation solid-state digital photon counting PET/CT (dPET/CT) technology and imaging findings in patients following 90Y microsphere radioembolization in comparison with standard of care (SOC) bremsstrahlung SPECT/CT (bSPECT/CT). METHODS: Five patients underwent SOC 90Y bremsstrahlung imaging immediately following routine radioembolization with 3.5 ± 1.7 GBq of 90Y-labeled glass microspheres. All patients also underwent dPET/CT imaging at 29 ± 11 h following radioembolization. Matched pairs comparison was used to compare image quality, image contrast and 90Y biodistribution between dPET/CT and bSPECT/CT images. Volumetric assessments of 90Y activity using different isocontour thresholds on dPET/CT and bSPECT/CT images were also compared. RESULTS: Digital PET/CT consistently provided better visual image quality and 90Y-to-background image contrast while depicting 90Y biodistribution than bSPECT/CT. Isocontour volumetric assessment using a 1% threshold precisely outlined 90Y activity and the treatment volume on dPET/CT images, whereas a more restrictive 20% threshold on bSPECT/CT images was needed to obtain comparable treatment volumes. The use of a less restrictive 10% threshold isocontour on bSPECT/CT images grossly overestimated the treatment volume when compared with the 1% threshold on dPET/CT images. CONCLUSIONS: Digital PET/CT is clinically feasible for the assessment of 90Y microsphere biodistribution following radioembolization, and provides better visual image quality and image contrast than routine bSPECT/CT with comparable acquisition times. With further optimization and clinical validation, dPET technology may allow faster and more accurate imaging-based assessment of 90Y microsphere biodistribution.
引用
- Wright CL, Binzel K, Zhang J, et al. Clinical feasibility of 90Y digital PET/CT for imaging microsphere biodistribution following radioembolization. Eur J Nucl Med Mol Imaging. 2017. PMID: 28405728. doi:10.1007/s00259-017-3694-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。